Reporte zur Charge WN5318

Symptomtext

slight discomfort at injection site; feeling of fatigue, not severe but noticeable; This is a spontaneous report from a non-contactable consumer (patient). A 31-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: WN5318, Expiration Date: unknown), via an unspecified route of administration, administered in left arm on 29Jan2021 at 11:45 (age at vaccination was 31 years) as a 1ST DOSE, SINGLE for COVID-19 immunization. The patient's medical history included peanut allergy. Concomitant medications the patient received within 2 weeks of vaccination included cyanocobalamin (VITAMIN B12) (50 ug vitamin B12/day) and colecalciferol (VITAMIN D) (1000 IU vitamin D/day). The patient previously took sulfamethoxazole and trimethoprim (BACTRIM) which caused drug allergy. On 29Jan2021 at 12:00 pm, the patient experienced slight discomfort at injection site, feeling of fatigue, not severe but noticeable. The patient responded "not recovered" but kept in mind that a very short time had elapsed between the adverse event and reporting. The facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment received for the adverse events. The events were reported as non-serious. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.